smithkline skb aim pct earn raise smithkline beckman pursue threepoint stragey achieve pct annual increase operate earn throughout remainder decade smithkline earn million dollar dollar share revenue dollar company annual report nonpharmaceutical business play major role meet earn growth target grow faster pharmaceutical business smithkline major product antiulcer medication tagamet report intend improve earn exist product expand product portfolio optimize financial resource bolster position antiulcer market tagamet stiff competition smithkline strategy develop overthecounter version tagamet bolster joint venture wellcome plc pending venture japan smithkline allergan eye care product division dlr organization grow pct annually nondilutive acquisition possibility gavin herbert president eye care product report allergan worldwide sale million dollar smith kline french laboratory pharmaceutical unit sale dollar file food drug administration market approval cardiovascular agent include tissue plasminogen activator sale force pct larger sale personnel smith kline clinical laboratory test unit sale million dollar perform million test increase employee drug test test aid antibody smith kline depend share price cost money buy share buy pct share smithkline begin management team include chief operate officer george ebright 
